Nipro Medical Corporation
Nipro corporate headquarters are located in Japan with manufacturing facilities in Thailand, China and Japan. Annual revenue exceeds 1.7 billion USD. Nipro has capabilities include cannula forming, plastic and extrusion injection molding, automated assembly, packaging, sterilization in house; ETO, gamma, steam and e-beam (8) ETO and stabilization chambers on site. Nipro has onsite 100,000 and 10,000 class clean rooms. Onsite design engineering department, R&D, prototyping, testing, verification and Quality Assurance labs. Nipro supports all phases of US FDA and are registered with Food and Drug Administration. Nipro is certified to ISO 13485 TUV P.S., ISO 9001 and OMS (Japan) Standards.